ARYA Sciences Acquisition Corp II Business Finance Contracts & Agreements
26 Contracts & Agreements
- Funding Agreements (2 contracts)
- Indenture Agreements (2)
- Note Agreements (1)
- Purchase Agreements (2)
- Registration Rights Agreements (3)
- Share Agreements (1)
- Stock Agreements (3)
- Subscription Agreements (2)
- Underwriting Agreements (5)
- Waiver Agreements (2)
- Warrant Agreements (3)
- First Supplemental Indenture, dated as of August 1, 2024, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on August 1, 2024)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 27, 2024)
- Waiver, dated as of April 27, 2023, by and among Cerevel Therapeutics Holdings, Inc. and the investors party thereto (Filed With SEC on August 2, 2023)
- Indenture, dated as of August 16, 2022, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on August 16, 2022)
- Form of Underwriting Agreement (Filed With SEC on June 29, 2021)
- Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and BC Pinnacle Holdings, LP (Filed With SEC on May 17, 2021)
- Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and NovaQuest Co-Investment Fund XVI, L.P (Filed With SEC on May 17, 2021)
- Form of Subscription Agreement (Filed With SEC on March 24, 2021)
- Waiver, dated January 20, 2021, by and among Cerevel Therapeutics Holdings, Inc. and the investors party thereto (Filed With SEC on January 21, 2021)
- Amended and Restated Registration and Shareholder Rights Agreement, dated October 27, 2020, by and among Cerevel Therapeutics Holdings, Inc. and the stockholders party thereto (Filed With SEC on November 2, 2020)
- Registration and Shareholder Rights Agreement among the Company, the Sponsor and certain other equityholders named therein (Filed With SEC on June 9, 2020)
- Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on June 9, 2020)
- Private Placement Units Purchase Agreement between the Company and the Sponsor (Filed With SEC on June 9, 2020)
- Warrant Agreement between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on June 9, 2020)
- Underwriting Agreement among the Company, Jefferies LLC and Goldman Sachs & Co. LLC (Filed With SEC on June 9, 2020)
- Securities Subscription Agreement, dated March 2, 2020, between the Registrant and the Sponsor (Filed With SEC on May 29, 2020)
- Promissory Note, dated as of March 2, 2020, issued to the Sponsor (Filed With SEC on May 29, 2020)
- Form of Private Placement Units Purchase Agreement between the Registrant and the Sponsor (Filed With SEC on May 29, 2020)
- Form of Registration and Shareholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto (Filed With SEC on May 29, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 29, 2020)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 29, 2020)
- Specimen Warrant Certificate (Filed With SEC on May 29, 2020)
- Specimen Ordinary Share Certificate (Filed With SEC on May 29, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 29, 2020)
- Underwriting Agreement, dated as of October 11, 2023, by and between Cerevel Therapeutics Holdings, Inc. and Goldman Sachs & Co. LLC, as representative of the underwriters (Filed With SEC on October 12, 2023)
- Underwriting Agreement, dated as of August 11, 2022, by and among Cerevel Therapeutics Holdings, Inc., and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Jefferies LLC and... (Filed With SEC on August 12, 2022)
